commun
ksimon
coronaviru
mous
hepat
viru
could
infect
via
haemagglutininsial
acid
interact
facilit
secondari
viru
infect
requir
sialic
acidbind
properti
haemagglutinin
sinc
uncleav
haemagglutinin
could
also
mediat
viru
entri
use
filtergrown
madindarbi
canin
kidney
mdck
cell
explor
mechan
influenza
viru
facilit
secondari
viru
infect
vesicular
stomat
viru
vsv
semliki
forest
viru
sfv
infect
basolater
surfac
polar
epitheli
cell
apic
surfac
prior
infect
influenza
viru
render
cell
suscept
infect
vsv
sfv
either
surfac
presenc
permiss
restrict
surfac
viru
entri
cell
allow
us
determin
influenza
infect
enhanc
subsequ
infect
second
viru
biochem
morpholog
evid
show
influenza
haemagglutinin
apic
surfac
serv
receptor
superinfect
viru
bind
sialic
acidbear
envelop
protein
influenza
viru
also
facilit
secondari
viru
infect
nonepitheli
cell
babi
hamster
kidney
cell
normal
resist
infect
introduct
interact
two
anim
virus
infect
tissu
compris
complex
array
phenomena
often
establish
one
viru
infect
tissu
interfer
suscept
second
anim
viru
infect
mani
mechan
interfer
character
rang
effect
level
entri
inactiv
cell
surfac
receptor
level
replic
competit
host
cell
compon
requir
viral
protein
synthesi
level
propag
mediat
interferon
fenner
et
al
complementari
set
interact
infect
one
viru
increas
suscept
tissu
second
viru
infect
also
describ
complement
occur
mani
system
particularli
well
studi
retrovir
system
dickson
et
al
special
type
complement
occur
envelop
virus
differ
famili
mutant
viru
often
vesicular
stomat
viru
vsv
defect
envelop
protein
replic
cell
bear
envelop
protein
anoth
viru
result
mix
pseudotyp
virion
produc
bear
envelop
protein
one
viru
intern
protein
irl
press
limit
oxford
england
zavada
enhanc
distinguish
complement
denot
interact
mix
infect
unrel
virus
result
increas
viru
product
andor
cytopath
effect
fenner
et
al
although
phenomena
clearli
import
understand
viral
pathogenesi
mechan
enhanc
known
case
replic
interferonsensit
virus
vsv
enhanc
tissu
preinfect
paramyxovirus
suppress
product
interferon
hermodsson
cantel
vall
frothingham
facilit
noninterferonmedi
enhanc
also
describ
ginder
friedewald
padgett
walker
tsuchiya
tagaya
howev
lack
conveni
welldefin
model
system
made
elucid
mechan
process
difficult
simpl
rodriguezboulan
multilay
klenk
epitheli
cell
provid
model
system
viru
infect
organ
tissu
found
vivo
best
character
model
epitheli
system
madindarbi
canin
kidney
mdck
cell
line
origin
develop
studi
transport
process
epithelia
subsequ
adapt
studi
viru
infect
rodriguezboulan
confluent
mdck
cell
link
circumferenti
tight
junction
epitheliumlik
sheet
tight
junction
defin
two
distinct
domain
plasma
membran
apic
correspond
lumin
surfac
renal
tubul
basolater
correspond
seros
surfac
rodriguezboulan
sabatini
show
viru
matur
observ
polar
mdck
cell
influenza
parainfluenza
virus
matur
apic
surfac
vsv
bud
exclus
basolater
surfac
polar
viru
matur
appear
consequ
polar
local
viral
envelop
protein
sinc
g
protein
vsv
locat
predominantli
basolater
surfac
haemagglutinin
neuraminidas
influenza
predominantli
apic
surfac
rodriguezboulan
pendergast
extend
observ
polar
viru
infect
use
mdck
monolay
grown
larg
pore
tm
nitrocellulos
filter
allow
access
viru
either
surfac
monolay
envelop
anim
virus
exhibit
infect
polar
parallel
matur
polar
vsv
exampl
infect
polar
mdck
cell
basolater
surfac
influenza
viru
infect
cell
surfac
sialic
acidbear
serum
protein
filter
inhibit
infect
model
system
would
seros
side
vivo
vsv
infect
polar
appear
reflect
receptor
polar
first
observ
phenomenon
describ
doubl
infect
experi
mdck
cell
monolay
grown
plastic
system
differ
filter
system
apic
surfac
monolay
expos
infect
condit
primari
vsv
infect
rel
ineffici
develop
slowli
contrast
mdck
monolay
preinfect
influenza
viru
fowl
plagu
viru
fpv
becam
suscept
vsv
infect
apic
surfac
although
interferonmedi
enhanc
vsv
infect
describ
cantel
vall
rapid
effect
appear
fact
protein
virus
express
cell
exclud
mechan
complement
also
rule
viru
replic
effici
introduc
cell
appropri
surfac
therefor
system
present
previous
uncharacter
type
enhanc
phenomenon
seem
tie
epitheli
natur
system
might
therefor
relev
dual
viru
infect
epithelia
vivo
employ
highli
polar
filtergrown
mdck
cell
demonstr
enhanc
vsv
infect
influenzainfect
mdck
cell
result
abil
influenza
haemagglutinin
cell
surfac
act
receptor
entri
vsv
bind
sialic
acidbind
vsv
g
protein
first
demonstr
interact
mediat
infect
previous
resist
cell
surfac
mechan
limit
vsv
epitheli
cell
cell
surfac
haemagglutinin
also
mediat
apic
infect
semliki
forest
viru
sfv
mdck
cell
well
infect
nonpolar
babi
hamster
kidney
cell
mous
hepat
viru
coronaviru
influenza
infect
mediat
vsv
entri
apic
surfac
mdck
abil
influenza
infect
mediat
apic
infect
mdck
vsv
shown
figur
vsv
appli
apic
basolater
b
surfac
mdck
monolay
grown
pore
size
filter
variou
time
infect
avian
influenza
fpv
mock
infect
protein
synthesi
cell
h
vsv
applic
monitor
pulsechas
experi
absenc
fpv
infect
vsv
infect
monolay
effici
appli
basolater
surfac
prior
infect
fpv
render
cell
suscept
vsv
infect
either
surfac
greater
polar
filtergrown
cell
render
effect
much
clearer
sinc
apic
vsv
infect
absolut
depend
fpv
preinfect
rate
vsv
protein
synthesi
basolater
infect
presenc
absenc
fpv
preinfect
similar
data
shown
suggest
major
effect
fpv
preinfect
limit
facilit
entri
previous
resist
apic
surfac
mobil
shift
g
protein
presenc
fpv
infect
reflect
intracellular
contact
envelop
protein
fpv
neuraminidas
vsv
g
protein
two
virus
confirm
express
cell
infect
fpv
increas
vsv
bind
apic
surfac
mdck
incub
uninfect
mdck
monolay
high
concentr
vsv
ugml
h
ie
particlescel
result
detect
bind
virion
apic
surfac
electron
microscop
examin
cell
sever
experi
never
reveal
bound
vs
virion
data
shown
contrast
parallel
experi
mdck
monolay
h
fpv
infect
show
extens
bind
vsv
apic
surfac
shown
henc
increas
suscept
apic
infect
seen
figur
accompani
appear
vsv
bind
site
surfac
apic
vsv
bind
site
could
repres
receptor
capabl
mediat
vsv
entri
normal
resist
surfac
receptor
appear
fpv
infect
would
basi
enhanc
vsv
infect
therefor
compar
characterist
fpvinduc
bind
fpvinduc
infect
issu
bind
infect
must
consid
separ
particularli
case
vsv
whose
normal
cell
surfac
receptor
remain
uncharacter
see
howev
schlegel
et
al
whose
bind
cell
surfac
satur
miller
lenard
matlin
et
al
one
plausibl
basi
bind
vsv
would
well
character
affin
surfac
express
influenza
haemagglutinin
sialic
acidbear
glycan
review
see
compan
choppin
schulz
g
protein
vsv
interact
suffici
stabl
enabl
inhibit
influenza
haemagglutin
vsv
use
assay
viru
compan
mdck
system
influenza
haemagglutinin
would
act
vsv
receptor
characterist
fpvmediat
infect
would
mirror
interact
altern
polar
cell
surfac
integr
tight
junction
might
destroy
cytopath
effect
fpv
infect
apic
appli
vsv
would
access
receptor
basolater
uninfect
polar
cell
characterist
fpvinduc
receptor
would
match
basolater
vsv
receptor
uninfect
cell
second
possibl
would
infect
cell
contain
receptor
apic
surfac
vsv
mask
uninfect
cell
case
influenza
infect
would
modifi
surfac
uncov
exist
receptor
influenza
neuraminidas
exampl
could
remov
sialic
acid
gangliosid
apic
surfac
allow
closer
approach
bind
neg
charg
vs
virion
biicher
pales
experi
design
distinguish
altern
express
influenza
haemagglutinin
apic
surfac
function
time
measur
indirect
radiometr
assay
use
antifpv
haemagglutinin
antibodi
figur
figur
show
amount
methioninelabel
vsv
bound
apic
surfac
mdck
cell
monolay
increas
time
fpv
infect
qualit
correl
influenza
haemagglutinin
express
bind
vsv
apic
surfac
shown
electron
microscop
result
confirm
quantit
result
shown
figur
express
influenza
haemagglutinin
preced
increas
vsv
bind
min
thereaft
two
rose
togeth
sialic
aciddepend
vsv
bind
fpvinfect
monolay
assay
use
neuraminidasetr
vsv
pretreat
vsv
clostridium
perfiringen
neuraminidas
condit
describ
materi
method
abolish
bind
vs
virion
fp
virion
assay
equilibrium
centrifug
figur
well
bind
fpvinfect
monolay
figur
fp
virionv
virion
complex
stabl
form
fpv
neuraminidas
abl
disrupt
interact
even
overnight
incub
must
reflect
lack
access
neuraminidas
haemagglutininbound
g
protein
viru
sinc
solubil
fpv
protein
readili
clear
sialic
acid
solubil
vsv
g
protein
vsv
bind
normal
receptor
mdck
iaemagglutiinmediated
sampl
infect
fpv
alon
h
fl
vsv
alon
apic
basal
surfac
h
well
mockinfect
u
sampl
includ
comparison
equal
count
load
onto
lane
compens
differ
methionin
incorpor
individu
viral
protein
label
left
comparison
fpvpreinfect
sampl
nonfpvinfect
one
clearli
show
increas
effici
vsv
infect
apic
surfac
reflect
viral
protein
synthesi
maximum
effect
seen
h
h
fpv
infect
cell
strongli
ph
depend
greater
ph
ph
miller
lenard
matlin
et
al
contrast
influenza
haemagglutinin
bind
sialic
acid
vari
slightli
ph
rang
figur
show
weak
depend
vsv
bind
ph
henc
consist
behaviour
bind
influenza
haemagglutinin
bind
perform
ph
ph
vsv
neuraminidasetr
vsv
neurvsv
standard
error
mean
point
shown
valu
larger
width
symbol
clear
correspond
increas
vsv
bind
haemagglutinin
express
seen
characterist
influenzamedi
vsv
infect
compar
vsv
bind
apic
surfac
immunofluoresc
experi
figur
show
vsv
infect
apic
surfac
depend
express
influenza
haemagglutinin
sialat
vsv
either
vsv
va
neuraminidasetr
vsv
nva
appli
apic
surfac
mdck
cell
monolay
either
h
influenza
infect
monolay
incub
h
allow
vsv
infect
develop
fix
process
immunofluoresc
monolay
infect
fpv
top
row
show
vsv
protein
express
vsv
va
neuraminidasetr
vsv
nva
appli
apic
surfac
neuraminidasetr
vsv
nyb
vsv
figur
fuller
et
al
infect
effici
basolater
surfac
fpv
infect
either
h
h
mediat
apic
vsv
infec
mdck
monolay
infect
fpv
variou
time
mockinfect
vsv
appli
apic
surfac
h
electr
resist
monolay
measur
initi
fpv
infect
absorpt
vsv
apic
surfac
mean
time
point
sampl
standard
error
mean
shown
tion
increas
haemagglutinin
express
h
h
fpv
infect
accompani
correspond
increas
vsv
protein
express
h
applic
apic
surfac
versu
neuraminidasetr
vsv
never
infect
apic
surfac
possibl
effect
influenza
neuraminidas
action
cell
surfac
simul
treatment
unitsml
solubl
neuraminidas
c
perfringen
time
neuraminidas
activ
contain
fpv
produc
h
infect
increas
apic
vsv
infect
seen
follow
treatment
intact
cell
monolay
throughout
fpv
infect
vsv
absorpt
period
monitor
measur
transepitheli
resist
resist
monolay
remain
ohm
tabl
characterist
apic
vsv
infect
mirror
vsv
bind
seen
figur
support
mechan
bind
vsv
sialic
acid
influenza
haemagglutinin
cell
surfac
mediat
entri
viru
neither
effect
influenza
neuraminidas
action
depolar
exist
receptor
account
influenzamedi
infect
time
depend
process
exclud
possibl
bind
whole
fp
virion
mediat
vsv
infect
earli
time
input
fpv
would
present
cell
surfac
produc
first
h
infect
yet
apic
vsv
infect
seen
newli
synthes
haemagglutinin
appear
infect
mdck
cell
monolay
alphaviru
sfv
display
polar
parallel
vsv
figur
sfvinfect
mdck
monolay
appli
basolater
surfac
sb
applic
apic
surfac
sa
sfv
infect
result
viral
protein
synthesi
product
viru
particl
data
shown
immunofluoresc
stain
cell
surfac
reveal
envelop
protein
predominantli
express
basolater
surfac
although
small
fraction
seen
apic
surfac
cell
rel
effici
apic
basolater
infect
compar
count
number
cell
infect
applic
vari
amount
sfv
either
surfac
tabl
ii
quantit
show
basolater
sfv
infect
least
time
effici
apic
low
background
level
sfv
apic
infect
made
effect
influenza
preinfect
strike
five
hour
influenza
infect
dramat
increas
time
number
cell
could
infect
sfv
apic
surfac
neuraminidas
treatment
sfv
abolish
influenzamedi
apic
infect
n
leav
basolater
infect
unalt
n
sb
electron
microscopi
show
bind
sfv
apic
surfac
uninfect
mdck
cell
monolay
data
shown
five
hour
fpv
infect
howev
result
extens
apic
sfv
bind
high
transmonolay
electr
resist
ohm
also
maintain
throughout
experi
data
shown
influenzamedi
infect
mechan
characteriz
fig
vsv
infect
fpvpreinfect
cell
mdck
cell
monolay
infect
vsv
andor
fpv
variou
period
fix
permeabil
triton
process
indirect
immunofluores
use
antibodi
direct
fpv
haemagglutinin
vsvg
protein
other
top
row
monolay
challeng
neuraminidasetr
vsv
basal
surfac
nvb
vsv
apic
surfac
va
neuraminidasetr
vsv
apic
surfac
nva
incub
h
allow
infect
develop
fixat
middl
row
monolay
infect
fpv
h
fix
challeng
vsv
neuraminidasetr
vsv
apic
side
incub
h
allow
vsv
infect
develop
bottom
row
monolay
infect
fpv
h
fix
challeng
vsv
neuraminidasetr
vsv
apic
side
incub
h
allow
vsv
infect
develop
imag
present
magnif
field
contain
cell
bar
repres
jxm
epitheli
cell
cell
resist
viru
lack
appropri
surfac
receptor
may
render
suscept
viru
follow
influenza
viru
infect
long
superinfect
viru
sialic
acid
residu
envelop
coronavirus
typic
limit
host
rang
sturmann
holm
cell
complet
resist
infect
coronaviru
even
pfucel
appli
figur
corbhk
corbhkph
tooz
et
al
use
system
show
bind
function
haemagglutinin
requir
mediat
entri
virus
haemagglutinin
influenza
viru
n
cleav
hajand
mammalian
cell
line
result
influenza
n
haemagglutinin
retain
abil
bind
sialic
acid
abil
catalys
low
phmediat
fusion
klenk
et
al
white
et
al
infect
cell
n
viru
led
product
surfac
haemagglutinin
fpv
haemagglutinin
incap
catalys
fusion
lipid
vesicl
contain
influenza
viru
receptor
cell
surfac
unless
exogen
proteas
ad
cleav
haemagglutinin
g
van
shown
surfac
influenza
haemagglutinin
mediat
entri
infect
sialic
acidbear
virus
normal
resist
cell
surfac
infect
vsv
sfv
multistep
process
involv
receptormedi
endocytosi
lenard
miller
white
et
al
fact
fusion
vsv
directli
cell
surfac
mediat
infect
matlin
et
al
lenard
miller
natur
receptor
involv
viru
infect
remain
unclear
sinc
virus
evolv
overcom
cellular
defenc
assum
infect
via
broad
rang
potenti
receptor
lenard
miller
kielian
heleniu
inde
bind
experi
vsv
sfv
reveal
thousand
bind
site
permiss
cell
miller
lenard
matlin
et
al
marsh
heleniu
lipid
phosphatidylserin
even
propos
receptor
vsv
schlegel
et
al
whether
bind
site
mediat
infect
unknown
howev
multipl
led
pictur
viral
endocytosi
differ
specif
receptormedi
endocytosi
ligand
insulin
transferrin
lenard
miller
differ
emphas
recent
review
bretscher
pears
multipl
weak
interact
viru
receptor
invok
allow
viru
entri
without
receptor
cluster
author
suggest
viru
roll
around
cell
surfac
continu
make
break
weak
bond
individu
receptor
encount
cluster
receptor
coat
pit
endocytosi
ensu
mechan
would
difficult
examin
previous
avail
system
contain
mani
potenti
receptor
system
describ
allow
studi
viral
entri
receptor
whose
bind
local
character
g
proteinhaemagglutinin
interact
quit
stabl
even
figur
immunoelectron
microscopi
shown
major
cell
surfac
influenza
haemagglutinin
cluster
coat
pit
rindler
et
al
spread
plasma
membran
surfac
two
fact
taken
togeth
suggest
viru
must
gather
cluster
receptor
enter
coat
pit
henc
endocytosi
viru
receptor
would
differ
ligand
epiderm
growth
factor
insulin
whose
receptor
also
cluster
enter
coat
pit
maxfield
et
al
schlessing
et
al
hopkin
et
al
present
result
also
confirm
previou
supposit
viru
infect
polar
consequ
viru
receptor
polar
elabor
apic
vsv
bind
site
suffici
mediat
apic
infect
coronaviru
experi
uncleav
haemagglutinin
show
bind
activ
protein
necessari
togeth
result
valid
infect
polar
measur
cell
surfac
polar
previou
work
vsv
infect
pore
size
filter
show
basolater
infect
least
effici
apic
infect
smaller
size
sf
virion
enabl
infect
effici
im
pore
size
filter
appear
give
mdck
cell
monolay
greater
mechan
stabil
minim
problem
monolay
leaki
allow
us
demonstr
mdck
cell
display
least
greater
effici
basal
sfv
infect
apic
interpret
ratio
term
receptor
concentr
must
take
account
measur
ratio
apic
basolater
surfac
area
cell
von
bonsdorff
et
al
well
possibl
one
receptor
may
requir
initi
bind
event
howev
result
demonstr
epitheli
cell
capabl
exquisit
control
composit
surfac
domain
tion
surfac
domain
potenti
import
phenomenon
haemagglutininmediaa
viru
entri
initi
infect
epithelium
illustr
magnitud
infect
polar
epithelium
vivo
least
polar
vitro
model
henc
influenza
infect
could
increas
suscept
epithelium
lumin
infect
initi
infect
could
spread
usual
rout
eg
along
seros
surfac
exampl
chose
demonstr
viral
protein
cell
surfac
mediat
entri
virus
intend
illustr
rather
exhaust
parainfluenza
virus
exampl
abl
mediat
infect
mechan
sinc
envelop
protein
also
sialic
acidbind
activ
phenomenon
appli
mani
combin
virus
must
consid
along
immunosuppress
interferonsuppress
activ
mechan
increas
suscept
secondari
infect
cell
virus
madin
darbi
canin
kidney
cellsstrain
mdck
vesicular
stomat
viru
indiana
strain
vsv
fpv
afpvrostock
ni
fuller
et
al
growth
cell
filter
describ
fuller
et
al
day
except
monolay
grown
mm
diamet
ytm
pore
size
millipor
filter
experi
cell
reach
higher
densiti
x
cellsfilt
day
growth
pore
size
filter
balcarovastand
et
al
saccel
line
murin
fibroblast
nonproduct
transform
murin
sarcoma
viru
grown
stock
provid
stooz
embl
growth
describ
tooz
et
al
except
viru
produc
eagl
minimum
essenti
medium
supplement
wv
bovin
serum
albumin
bsa
mm
hepe
umil
penicillin
ytgml
streptomycin
emem
sfv
prepar
describ
white
et
al
n
viru
isol
van
meer
simon
methioninelabel
vsv
grown
cell
describ
pesonen
simon
leucinelabel
fpv
grown
harvest
strain
ii
mdck
cell
use
procedur
parallel
describ
methioninelabel
fpv
matlin
et
al
infect
filtergrown
monolay
strain
mdck
cell
perform
minimarbrook
chamber
allow
monitor
transepitheli
resist
richardson
simmon
fuller
et
al
filter
chamber
rins
dip
edgewis
beaker
contain
emem
excess
medium
aspir
basal
apic
side
filter
without
touch
filter
viru
emem
appli
one
surfac
aliquot
emem
appli
surfac
filter
holder
place
feet
deep
x
mm
diamet
well
dish
nunc
contain
emem
mm
filter
whatman
soak
emem
place
atop
collar
chamber
dish
cover
place
incub
h
allow
viru
absorpt
rins
three
time
growth
medium
filter
holder
incub
ml
growth
medium
incub
measur
avoid
develop
hydrostat
pressur
could
damag
monolay
manipul
chamber
alway
insert
edgewis
solut
kept
fill
float
maintain
long
time
solut
monolay
alway
incub
presenc
bsa
serum
loss
resist
observ
incub
proteinfre
solut
precaut
observ
filtergrown
monolay
display
initi
resist
ohm
could
routin
rnanipul
maintain
resist
least
h
monolay
lower
initi
origin
resist
appear
fragil
infect
subconflu
saccel
coronaviru
perform
describ
tooz
et
al
except
viru
appli
emem
infect
cell
fpv
influenza
n
viru
perform
bare
confluent
monolay
x
glass
coverslip
mm
dish
monolay
rins
twice
emem
pfucel
influenza
pfucel
dilut
emem
appli
volum
ml
dish
cover
place
incub
h
allow
absorpt
monolay
rins
incub
growth
medium
neuraminidas
digest
vsv
sfv
perform
incub
viru
h
hank
basal
salt
solut
contain
bsa
sigma
gmbh
frg
mm
hepe
ph
bssbsa
concentr
least
x
pfuml
mgmi
c
perfringen
neuraminidas
type
ivsigma
gmbh
frg
similar
treatment
coronaviru
inde
incub
bssbsa
h
absenc
neuraminidas
caus
essenti
complet
loss
infect
reason
coronaviru
digest
perform
ice
h
concentr
viru
neuraminidas
case
viru
dilut
mgml
neuraminidas
appli
cell
surfac
absorpt
control
virus
alway
use
parallel
incub
emem
without
neuraminidas
parallel
infect
serial
dilut
control
neuraminidasetr
virus
assay
immunofluoresc
show
loss
infect
due
neuraminidas
treatment
digest
condit
describ
analysi
fpvvsv
bind
tartrat
gradient
ww
continu
potassium
tartrat
gradient
nacl
mm
triscl
ph
prepar
ml
beckman
tube
viru
sampl
mix
bssbsa
either
load
atop
gradient
immedi
incub
overnight
load
gradient
centrifug
h
rpm
beckman
rotor
g
centrifug
time
h
necessari
observ
separ
fpv
vsv
peak
ml
fraction
taken
across
gradient
appli
mm
diamet
whatman
filter
bssbsa
three
applic
applic
filter
allow
dri
filter
process
scintil
count
describ
man
novelli
count
liquid
scintil
counter
searl
oper
mode
count
display
percent
total
count
recov
gradient
correct
spillov
channel
typic
x
cpm
per
viru
use
gradient
recov
fraction
viru
bind
assay
plexiglass
filter
holder
construct
embl
workshop
use
viru
bind
assay
devic
consist
upper
block
contain
hole
clamp
lower
block
correspond
depress
rubber
mm
diamet
fit
around
bottom
hole
form
seal
cell
monolay
isol
well
neighbor
electr
resist
filter
measur
individu
minimarbrook
chamber
current
clamp
devic
describ
fuller
et
al
move
room
oper
perform
filter
remov
chamber
rins
bssbsa
laid
atop
bssbsasoak
mm
diamet
filter
whatman
apic
surfac
clamp
precool
plexiglass
filter
holder
apic
surfac
rins
ml
bssbsa
excess
fluid
aspir
well
radioact
viru
ad
al
total
volum
filter
holder
cover
parafilm
amer
co
greenwich
ct
set
ice
atop
shaker
allow
bind
occur
incub
h
viru
remov
apic
surfac
wash
twice
bssbsa
filter
remov
plexiglass
holder
wash
separ
ml
mm
dish
nunc
algad
denmark
three
time
ml
bssbsa
shake
min
ice
basal
surfac
filter
blot
whatman
paper
entir
filter
cell
count
rotiscint
carl
roth
karlsruh
frg
mark
liquid
scintil
counter
bind
experi
electron
microscopi
mdck
monolay
grown
day
itm
pore
size
filter
infect
pfucel
fpv
apic
surfac
mockinfect
filter
remov
chamber
h
infect
rins
icecold
pb
contain
pb
transfer
room
oper
perform
mm
squar
piec
cut
filter
blot
edgewis
filter
paper
immers
pb
contain
either
mg
vsv
mg
sfv
mm
plastic
dish
dish
cover
held
ice
h
incub
viru
piec
filter
rins
pb
fix
glutaraldehyd
sodium
cacodyl
ph
min
process
fix
filter
electron
microscopi
complet
describ
fuller
et
al
antibodi
immunofluoresc
immunofluoresc
stain
filtergrown
mdck
monolay
perform
use
affinitypurifi
antibodi
describ
fuller
et
al
except
wv
newborn
calf
serum
use
place
gelatin
cell
saccel
grown
coverslip
process
immunofluoresc
permeabil
triton
describ
louvard
use
either
affinitypurifi
rabbit
anti
fpvhaemagglutinin
rabbit
antibodi
direct
protein
describ
tooz
et
al
antibodi
visual
stain
goat
antirabbit
igg
conjug
rhodamin
louvard
stain
either
uninfect
cell
cell
infect
virus
observ
antibodi
protein
assay
fpv
apic
surfac
express
filtergrown
monolay
fix
paraformaldehyd
quench
ammonium
chlorid
rins
pb
pb
contain
wv
gelatin
pbsgelatin
describ
fuller
et
al
whole
filter
laid
apic
surfac
al
drop
antifpvhaemagglutinin
antibodi
jigml
pbsgelatin
hydrat
chamber
left
c
min
filter
remov
antibodi
wash
twice
pb
gelatin
min
shake
filter
laid
atop
ji
drop
pbsgelatin
contain
ng
protein
cpm
protein
amersham
hydrat
chamber
incub
protein
min
filter
wash
twice
pb
gelatin
twice
pbsfor
min
shake
outer
rim
filter
remov
cork
bore
central
mm
filter
count
gamma
counter
nuclear
scienc
chicago
method
pulsechas
experi
cell
count
gel
electrophoresi
perform
describ
fuller
et
al
